Caxton Associates (New York)’s CareDx CDNA Stock Holding History

Caxton Associates (New York)’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	$720K	Sell	33,619 -2,661	-7%	-$64.7K	0.02%	271
2024 Q3	$1.13M	Buy	+36,280	New	+$903K	0.04%	220
2024 Q2	–	Sell	-96,308	Closed	-$1.02M	–	488
2024 Q1	$1.02M	Buy	96,308 +47,469	+97%	+$475K	0.06%	215
2023 Q4	$586K	Hold	48,839	–	–	0.03%	299
2023 Q3	$342K	Buy	48,839 +21,105	+76%	+$195K	0.05%	291
2023 Q2	$236K	Buy	+27,734	New	+$231K	0.03%	388
2020 Q3	–	Sell	-8,948	Closed	-$317K	–	336
2020 Q2	$317K	Buy	+8,948	New	+$255K	0.03%	240
2018 Q4	–	Sell	-6,965	Closed	-$201K	–	303
2018 Q3	$201K	Buy	+6,965	New	+$130K	0.01%	377

Other funds holding CDNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Caxton Associates (New York)'s CDNA Position: Q4 2024 in Review

Caxton Associates (New York) reduced its CareDx (CDNA) stake by 7.3% in Q4 2024, selling an estimated $64.7K and leaving 33,619 shares worth $720K. The position accounts for 0.02% of the portfolio, ranked #271.

Caxton Associates (New York) first reported a position in CDNA in Q3 2018 and has held it in 8 quarters since. The position peaked at $1.13M in Q3 2024. 210 funds tracked by Wall St. Rank hold CDNA as of Q4 2024.

Caxton Associates (New York) held 33,619 shares of CareDx worth $720K as of Q4 2024.
Caxton Associates (New York) sold 2,661 CareDx shares in Q4 2024, an estimated $64.7K.
CareDx made up 0.02% of Caxton Associates (New York)'s portfolio in Q4 2024, its #271 holding.
Caxton Associates (New York) first reported a position in CareDx in Q3 2018 and has held it in 8 quarters since.
Caxton Associates (New York)'s CareDx position peaked at $1.13M in Q3 2024.
210 funds tracked by Wall St. Rank held CareDx as of Q4 2024.

Based on Caxton Associates (New York)'s 13F filing for Q4 2024, filed 14 Feb 2025.